Axe Compute Inc. reported a significant decline in financial performance for the first quarter of 2026, with revenues totaling $35,311, a decrease of approximately 68% from $110,310 in the same period of 2025. The company also recorded a substantial loss on digital assets amounting to $4,296,268, which was not present in the previous year. This contributed to a total operating loss of $7,728,681, compared to a loss of $2,287,047 in the prior year. The net loss for the quarter was $7,708,943, translating to a loss per share of $0.36, a notable increase from a loss of $5.12 per share in the same quarter last year.
The company's financial position has also changed, with total assets decreasing to $45.2 million as of March 31, 2026, down from $52.9 million at the end of 2025. Cash and cash equivalents fell to $6.9 million, a decline from $10.8 million. The accumulated deficit increased to $421.2 million, reflecting ongoing operational challenges. General and administrative expenses rose significantly to $2.9 million, primarily due to severance costs related to the termination of the former CEO and increased payroll expenses.
Strategically, Axe Compute has been focusing on its Treasury Strategy, which involves managing a digital asset treasury centered on the Aethir token (ATH). The company aims to acquire additional ATH and engage in staking activities to generate yield. However, as of March 31, 2026, the company had not yet commenced staking activities. The company is also exploring strategic alternatives for its legacy oncology drug discovery business, which has seen limited operations since the rebranding from Predictive Oncology Inc.
Operationally, the company has made significant changes, including the appointment of new leadership. Kyle Okamoto was appointed as President on April 1, 2026, and Jeremy Yaukey-Witter was named Co-Chief Financial Officer, set to take over fully after May 18, 2026. Additionally, Axe Compute announced a major enterprise infrastructure contract valued at approximately $260 million, which is expected to support large-scale AI model training and is set to commence deployment in the third quarter of 2026. The company believes that its current liquidity, including cash reserves and digital assets, will be sufficient to fund operations for at least the next twelve months, despite the ongoing volatility in the digital asset market.
About Predictive Oncology Inc.
Predictive Oncology Inc. leverages artificial intelligence and a proprietary biobank of over 150,000 tumor samples to support cancer drug discovery and development. The company provides AI-driven predictive models, tumor-specific 3D cell culture models, and clinical tumor profiling tests. Its core markets include biopharmaceuticals, diagnostics, and healthcare providers, focusing on improving drug success rates, personalized treatments, and efficient oncology research.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.